Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes.

Authors :: Silverberg, Jonathan I.
Thyssen, Jacob P.
Simpson, Eric L.
Yosipovitch, Gil
Ständer, Sonja
Valdez, Hernan
Rojo, Ricardo
Biswas, Pinaki
Myers, Daniela E.
Feeney, Claire
DiBonaventura, Marco
Source :: American Journal of Clinical Dermatology; Sep2021, Vol. 22 Issue 5, p739-739, 1p
Publication Year :: 2021
Abstract: A correction to the article "Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adult with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes" in an issue is presented.

Subjects :: ORAL drug administration
HEALTH outcome assessment
HEALTH status indicators
SEVERITY of illness index
JANUS kinases
ATOPIC dermatitis
QUALITY of life
NEUROTRANSMITTER uptake inhibitors
EVALUATION
SYMPTOMS
ADULTS
ADOLESCENCE

Full Text Access

Tools